Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients

Bakkaloglu S. A., Buyan N., Funahashi T., Pasaoglu H., Elhan A., Hasanoglu E., ...Daha Fazla

PERITONEAL DIALYSIS INTERNATIONAL, cilt.25, sa.4, ss.357-361, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 4
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1177/089686080502500410
  • Dergi Adı: PERITONEAL DIALYSIS INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.357-361
  • Gazi Üniversitesi Adresli: Evet

Özet

Background. Atherosclerotic vascular diseases are the major cause of mortality in patients with end-stage renal disease (ESRD) treated with chronic peritoneal dialysis (CPD), even in children. Adiponectin (ADPN) is a recently discovered adipocyte-derived plasma protein having anti-atherogenic properties. ADPN levels are elevated in ESRD but-it has-been reported that ESRD patients with low plasma ADPN levels have a high risk of cardiovascular death.